Allergic comorbidities among inborn errors of immunity in children attended in a high-complexity center in Cali,

Jacobo Triviño-Arias1, Sofia Martínez-Betancur1, Oriana Arias-Valderrama1,2

  • 1Fundación Valle del Lili, Centro de Investigaciones Clínicas, Cali, Colombia.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|December 20, 2025
PubMed

Insights

Allergic diseases (AD) are common in children with inborn errors of immunity (IEI), often distinct from primary atopic diseases. Recognizing these comorbidities aids early IEI diagnosis and management.

Area of Science:

  • Pediatric Immunology
  • Allergy and Immunology
  • Genetics

Background:

  • Inborn errors of immunity (IEI) are a diverse group of genetic disorders affecting the immune system.
  • Allergic diseases (AD) are frequently observed in patients with IEI, but their distinct clinical characteristics as comorbidities require further elucidation.
  • Differentiating AD as comorbidities from primary atopic diseases (PAD) is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To describe the clinical characteristics of allergic diseases (AD) as comorbidities in pediatric patients diagnosed with inborn errors of immunity (IEI).
  • To distinguish these allergic comorbidities from primary atopic diseases (PAD).

Main Methods:

  • An observational, retrospective study included pediatric patients diagnosed with IEI and allergic comorbidity between 2013-2023.
  • Diagnoses were made according to ESID and IUIS-2022 criteria.
  • Descriptive analysis of variables and odds ratio (OR) for allergic sensitization were performed using R Studio.

Main Results:

  • Out of 366 IEI patients, 238 (65%) had concomitant AD.
  • The most common IEI types were antibody-specific deficiencies (84%) and combined immunodeficiencies (2.5%).
  • The most frequent ADs were asthma (48.7%), rhinitis (18.9%), and atopic dermatitis (15.1%).

Conclusions:

  • Allergic diseases are increasingly recognized as indicators for early IEI diagnosis.
  • AD can coexist with IEI without being primary atopic diseases, necessitating comprehensive care.
  • Recognizing this heterogeneity supports a multidisciplinary approach for improved early detection and management of IEI.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...